Download the report:
The genetic testing landsape 

Genetic testing has ushered in a new era of healthcare by providing personalised genetic information that shapes disease prevention, diagnosis, and treatment strategies. This report focuses on the dynamic landscape of genetic testing programs, with a spotlight on sponsored initiatives that enhance accessibility and inclusion. 

Download this report to:  
  • Gain insights into the power of genetic testing in healthcare to drive disease prevention, diagnosis, and treatment strategies.
  • Explore the landscape of genetic testing programs, with a special focus on sponsored initiatives that democratise access to genetic insights.
  • Understand the different types of genetic testing available, including disease risk assessments, pharmacogenetic testing, ancestry analysis, and lifestyle-related genetic tests.
  • Navigate the genetic testing process, from participant recruitment and sample collection, to data analysis and responsible result dissemination.
genetic testing graphic
download icon

Download report

Precision medicine strategies in neuromuscular diseases

Neuromuscular diseases (NMDs) like spinal muscular atrophy, Duchenne muscular dystrophy, and myasthenia gravis have long posed challenges due to their complexity and variability. In recent years, precision medicine has transformed how these rare conditions are treated, with shifts toward targeted, genetically-informed approaches that address the underlying biology of disease.

This report explores the latest advances in gene therapy, antisense oligonucleotides, and biomarker-driven strategies across a range of NMDs. It highlights key clinical findings, approved treatments, and ongoing trials, while also addressing the limitations that remain.

Download the report to discover how precision medicine is reshaping the future of neuromuscular disease care.

Group 5485-Jun-19-2025-10-57-21-7309-AM